
Global R&D Pipeline
My Favorite
Hot Targets:
A2aR
Back
Total number of drugs
238
Phase II and later clinical stages
44.5%
Involving companies
221
Main therapeutic areas
Nervous System Diseases
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
| Drug | Drug Name En | Drug Type | Treatment Field | Mechanism of Action | Originator | Developer | Indication | Highest Development Stage | Highest Development Stage (China) | Approved Countries/Regions | Approved Time | Approved Time (China) | Special Review | ADC Type | ADC Linker | ADC Payload | ADC DAR | Drug Name | Antibody Type | ADC Linking Site | Operation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KF-17837 | KF-17837 | Small molecule drug | Nervous System Diseases Endocrinology and Metabolic Disease | Adenosine A2a receptor antagonists | Kyowa Kirin Co., Ltd. | Pending | KF-17837 | detail > | |||||||||||||
| Lu AA41063 | Lu AA41063 | Small molecule drug | Nervous System Diseases Endocrinology and Metabolic Disease | Adenosine A2a receptor antagonists | H. Lundbeck A | Preclinical | Lu AA41063 | detail > | |||||||||||||
| LASSBio-1835 | LASSBio-1835 | Small molecule drug | Respiratory Diseases Other Diseases | Adenosine A2a receptor agonists Phosphodieterase 4 inhibitors | Federal University of Rio de Janeiro | Preclinical | LASSBio-1835 | detail > | |||||||||||||
| LASSBio-1386 | LASSBio-1386 | Small molecule drug | Respiratory Diseases Other Diseases | Adenosine A2a receptor agonists | Federal University of Rio de Janeiro | Preclinical | LASSBio-1386 | detail > | |||||||||||||
| LASSBio-1359 | LASSBio-1359 | Small molecule drug | Respiratory Diseases Other Diseases | Adenosine A2a receptor agonists | Federal University of Rio de Janeiro | Preclinical | LASSBio-1359 | detail > | |||||||||||||
| KW-6356 | KW-6356 | Small molecule drug | Nervous System Diseases Endocrinology and Metabolic Disease | Adenosine A2a receptor antagonists | Kyowa Kirin Co., Ltd. | Phase 2 | KW-6356 | detail > | |||||||||||||
| IHCH-3064 | IHCH-3064 | Small molecule drug | Neoplasms | Adenosine A2a receptor antagonists Histone deacetylase inhibitors Epigenetic drug | Shanghaitech University | Preclinical | Preclinical | IHCH-3064 | detail > | ||||||||||||
| GBV-2034 | GBV-2034 | Small molecule drug | Neoplasms | Adenosine A2a receptor antagonists | Globavir Biosciences, Inc. | Pending | GBV-2034 | detail > | |||||||||||||
| ID-11902 | ID-11902 | Small molecule drug | Neoplasms | Adenosine A2a receptor antagonists | Ildong Pharmaceutical Co., Ltd. | Preclinical | ID-11902 | detail > | |||||||||||||
| MRS-7145 | MRS-7145 | Small molecule drug | Nervous System Diseases Endocrinology and Metabolic Disease | Adenosine A2a receptor antagonists | University of Barcelona | Pending | MRS-7145 | detail > |
Total 238 data
1
2
3
4
5
6
...
23
24


